- Home
- EVCM vs ZLAB Comparison
EVCM vs ZLAB Comparison
Compare EVCM & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVCM
- ZLAB
- Stock Information
- Founded
- EVCM 2006
- ZLAB 2013
- Country
- EVCM United States
- ZLAB China
- Employees
- EVCM N/A
- ZLAB N/A
- Industry
- EVCM EDP Services
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- EVCM Technology
- ZLAB Health Care
- Exchange
- EVCM Nasdaq
- ZLAB Nasdaq
- Market Cap
- EVCM 2.2B
- ZLAB 3.4B
- IPO Year
- EVCM 2021
- ZLAB 2017
- Fundamental
- Price
- EVCM $11.72
- ZLAB $32.30
- Analyst Decision
- EVCM Buy
- ZLAB Buy
- Analyst Count
- EVCM 9
- ZLAB 6
- Target Price
- EVCM $11.89
- ZLAB $57.22
- AVG Volume (30 Days)
- EVCM 240.5K
- ZLAB 831.7K
- Earning Date
- EVCM 11-11-2025
- ZLAB 11-11-2025
- Dividend Yield
- EVCM N/A
- ZLAB N/A
- EPS Growth
- EVCM N/A
- ZLAB N/A
- EPS
- EVCM N/A
- ZLAB N/A
- Revenue
- EVCM $710,678,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- EVCM N/A
- ZLAB $42.62
- Revenue Next Year
- EVCM $5.95
- ZLAB $55.12
- P/E Ratio
- EVCM N/A
- ZLAB N/A
- Revenue Growth
- EVCM 14.15
- ZLAB 32.56
- 52 Week Low
- EVCM $8.10
- ZLAB $20.17
- 52 Week High
- EVCM $12.34
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- EVCM 57.34
- ZLAB 47.53
- Support Level
- EVCM $11.23
- ZLAB $26.67
- Resistance Level
- EVCM $11.75
- ZLAB $33.06
- Average True Range (ATR)
- EVCM 0.33
- ZLAB 1.38
- MACD
- EVCM 0.03
- ZLAB 0.15
- Stochastic Oscillator
- EVCM 64.00
- ZLAB 77.14
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.